| The relationship between mean platelet volume and neutrophil/lymphocyte ratio with inflammation and proteinuria in chronic kidney disease G Yilmaz, C Sevinc, S Ustundag, YC Yavuz, T Hacıbekiroglu, E Hatipoglu, ... Saudi Journal of Kidney Diseases and Transplantation 28 (1), 90-94, 2017 | 43 | 2017 |
| Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance M Baysal, U Demirci, E Umit, HO Kirkizlar, EI Atli, H Gurkan, SK Gulsaran, ... Scientific Reports 10 (1), 1-6, 2020 | 37 | 2020 |
| Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy EG Umıt, M Baysal, V Bas, I Asker, O Kırkızlar, AM Demır Journal of oncology pharmacy practice 26 (1), 43-50, 2020 | 21 | 2020 |
| Thalidomide for the management of bleeding episodes in patients with hereditary hemorrhagic telangiectasia: effects on epistaxis severity score and quality of life M Baysal, EG Ümit, HO Kırkızlar, AC Özdöver, AM Demir Turkish Journal of Hematology 36 (1), 43, 2019 | 14 | 2019 |
| Frailty in patients with acute myeloid leukaemia, conceptual misapprehension of chronological age EG Umit, M Baysal, AM Demir European Journal of Cancer Care 27 (2), e12810, 2018 | 13 | 2018 |
| CD 11c expression in chronic lymphocytic leukemia revisited, related with complications and survival EG Umit, M Baysal, Y Durmus, AM Demir International Journal of Laboratory Hematology 39 (5), 552-556, 2017 | 13 | 2017 |
| The utility of CONUT score in diffuse large B cell lymphoma patients M Baysal, V Bas, U Demirci, SK Gulsaran, E Umit, HO Kirkizlar, AM Demir Nigerian Journal of Clinical Practice 24 (8), 1194-1199, 2021 | 9 | 2021 |
| The incidence of venous thromboembolism and impact on survival in Hodgkin lymphoma O Kirkizlar, TA Kirkizlar, EG Umit, I Asker, M Baysal, V Bas, SK Gulsaran, ... Clinical Lymphoma Myeloma and Leukemia 20 (8), 542-547, 2020 | 9 | 2020 |
| Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia M Baysal, E Ümit, HO Kırkızlar, AM Demir Turkish Journal of Haematology: Official Journal of Turkish Society of …, 2021 | 7 | 2021 |
| Drug induced thrombotic microangiopathy with certolizumab pegol M Baysal, EG Ümit, F SARITAŞ, NS Kodal, AM Demir Balkan Medical Journal 35 (5), 398-399, 2018 | 7 | 2018 |
| Sarcopenia in Hodgkin’s lymphoma evaluated with 18-FDG PET/CT, focus on age, performance, and treatment V Bas, EG Umit, U Korkmaz, M Baysal, S Karaman Gulsaran, U Demirci, ... Supportive Care in Cancer 29 (5), 2475-2480, 2021 | 6 | 2021 |
| Is JAK2V617F mutation the only factor for thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms? MS Uyanik, M Baysal, GE Pamuk, M Maden, M Akker, EG Umit, M Demir, ... Indian Journal of Hematology and Blood Transfusion 32, 262-267, 2016 | 6 | 2016 |
| Late onset left ventricular dysfunction and cardiomyopathy induced with ibrutinib SK Gülsaran, M Baysal, U Demirci, V Baş, HO Kirkizlar, E Umit, AM Demir Journal of Oncology Pharmacy Practice 26 (2), 478-480, 2020 | 5 | 2020 |
| Value of extracellular high mobility group box 1 (HMGB1) in the clinical context of immune thrombocytopenia EG Umit, M Baysal, V Bas, H Goze, V Asoglu, O Kirkizlar, AM Demir Journal of Clinical and Experimental Investigations 10 (2), em00724, 2019 | 5 | 2019 |
| Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review M Baysal, M Bayrak, AE Eşkazan Expert Review of Hematology 16 (2), 131-140, 2023 | 4 | 2023 |
| Subacute thyroiditis after SARS-CoV-2 BNT162b2 vaccine in a multiple myeloma patient N Alkis, M Baysal SAGE Open Medical Case Reports 10, 2050313X221091392, 2022 | 4 | 2022 |
| Could antinuclear antibody positivity be a factor affecting treatment response in immune thrombocytopenia patients on eltrombopag? M Baysal, V Baş, E Ümit, HO Kırkızlar, AM Demir Turkish Journal of Hematology 39 (1), 38, 2022 | 4 | 2022 |
| Evaluation of Sarcopenia with F‐18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma EG Umit, U Korkmaz, M Baysal, S Karaman Gulsaran, V Bas, U Demirci, ... European Journal of Cancer Care 29 (6), e13318, 2020 | 4 | 2020 |
| The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study M Baysal, V Gürsoy, FC Hunutlu, B Erkan, U Demirci, V Bas, SK Gulsaran, ... Annals of Hematology 101 (5), 1049-1057, 2022 | 3 | 2022 |
| Could ratio of hemoglobin to red cell distribution width and ratio of absolute lymphocyte count to absolute monocyte count be a prognostic tool in newly diagnosed multiple … M Baysal, U Demirci, V Bas, SK Gulsaran, E Umit, HO Kirkizlar, S Baysal, ... Acta Haematologica Polonica 51 (2), 81-87, 2020 | 2 | 2020 |
